All In Biotech

Drug Trial Radar · NCT03567824

MLD10 for the Treatment of Hypomagnesemic Patients With Type 2 Diabetes Mellitus

A Phase 2 Open Label Study of Magnesium L-Lactate Dihydrate (MLD10) 10 mEq Extended-Release Caplets Administered BID for the Treatment of Hypomagnesemic Patients With Type 2 Diabetes Mellitus Followed by a Blinded Random Off Phase

Last checked: Nov 19, 2026Latest source record: Nov 27, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingRandomized with 200 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

200

Planned (sponsor's estimate)

Start

Mar 1, 2026

Primary completion

Apr 30, 2028

Study completion Apr 30, 2028

Sponsor

Lead sponsor
Pharmalyte Solutions LLCIndustry
Sponsor type
Industry
First posted
Jun 26, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To determine the effect of MLD10 (magnesium L-lactate dihydrate extended-release caplets) 10 mEq BID on serum magnesium in Type 2 diabetic patients with hypomagnesemia.

Conditions

  • Hypomagnesemia in Type 2 Diabetic Patients

Interventions

  • Magnesium L-lactate dihydrateDrug

    Magnesium L-lactate dihydrate 10 mEq extended release caplets

  • Placebo Oral TabletDrug

    Placebo will have the same appearance, taste, odor and mode of administration as MLD10.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Serum Magnesium ConcentrationTime frame: Three months after the initiation of treatment and then at 3 months after the start of the random off phase.

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.